Monday, November 30, 2015 11:59:50 PM
Titan Medical Inc. (Titan or the Company) (TSX: TMD) (OTCQX: TITXF) is pleased to announce that it has closed its previously announced public offering (the Offering) made pursuant to an agency agreement (the Agency Agreement) dated November 6, 2015 between the Company and Octagon Capital Corporation (the Agent). The Company has sold a base offering of 8,130,081 units (each, a Unit) and full over-allotment of an additional 1,219,512 Units at a price of CDN $1.23 per Unit for aggregate gross proceeds of approximately CDN $11,500,000.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM